Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DermaAngel is an active skincare and acne-care brand operated by BenQ Materials that markets hydrocolloid acne patches and related skin-care products. Its flagship products are non-drug or ingredient-enhanced acne patches designed to absorb exudate, protect blemishes, and support faster healing, alongside cleansers, conditioners, spot serums, and hydration-focused products. The brand appears focused on over-the-counter consumer dermatology rather than prescription therapeutics or clinical-stage drug development. DermaAngel sells internationally across Asia, North America, and Oceania through e-commerce and retail channels. Within a life-science taxonomy, it is best classified as a commercial consumer healthcare and medical-device-adjacent dermatology brand rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DermaAngel.